---
$id: https://graph.org.ai/products/commodity/51271610
$type: Product
source: UNSPSC
code: "51271610"
title: "Etidocaine"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Etidocaine

**UNSPSC Code**: 51271610
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C17H28N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I6CQM0F31V, chemically known as 2-(ethylpropylamino)-2,6-butyroxylidide but generally known as etidocaine, which bears US NIH Compound Identifier 37497. European Medicines Agency schedules Etidocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07298MIG. The term ETIDOCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules etidocaine in its Anatomical Therapeutic Chemical (ATC) Classification. ETIDOCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etidocaine under HS 29242995 and SITC 51479. As of Q4 2014, ETIDOCAINE remains the US FDA Preferred Term for this commodity. Etidocaine bears US NLM identifiers UMLS ID C0015120 and NCI Concept Code C65574. SMILES: O=C(NC1C(CCCC1C)C)C(N(CCC)CC)CC.

